Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0276640 (
TEM
)
20,729
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The structure of the 28 kDa beta-lactamase inhibitor protein-II (BLIP-II) in complex with the
TEM
-1 beta-lactamase has been determined to 2.3 A resolution. BLIP-II is a secreted protein produced by the soil bacterium Streptomyces exfoliatus SMF19 and is able to bind and inhibit
TEM
-1 with subnanomolar affinity. BLIP-II is a seven-bladed beta-propeller with a unique blade motif consisting of only three antiparallel beta-strands. The overall fold is highly similar to the core structure of the human regulator of chromosome condensation (
RCC1
). Although BLIP-II does not share the same fold with BLIP, the first beta-lactamase inhibitor protein for which structural data was available, a comparison of the two complexes reveals a number of similarities and provides further insights into key components of the
TEM
-1-BLIP and
TEM
-1-BLIP-II interfaces. Our preliminary results from gene knock-out studies and scanning electron microscopy also reveal a critical role of BLIP-II in sporulation.
...
PMID:Crystal structure and kinetic analysis of beta-lactamase inhibitor protein-II in complex with TEM-1 beta-lactamase. 1157 88
Introduction:
Curcuma wenyujin
is a plant which belongs to the family of
Zingiberaceae
, found in South Asia and China.
C. wenyujin
is a major constituent in Chinese traditional medicine and is used to treat liver diseases, blood clots, and is also prescribed as a painkiller.
C. wenyujin
possesses antioxidant, antiproliferative, and antitumorogenic properties, and many researchers have proved the efficacy of
C. wenyujin
against various types of cancer. The major drawback of this historical drug is it's low bioavailability.
Methods:
This study synthesized gold nanoparticles using
C. wenyujin
and assessed its potency against in vitro renal cancer cells. The biosynthesized
C. wenyujin
gold nanoparticles (CWAuNPs) were characterized using UV-Spec, DLS, FTIR, SAED,
TEM
, EDAX, and Atomic Force analysis. The cytotoxicity of CWAuNPs against renal cancer cell lines A498 and SW-156 was assessed with MTT assay. The induction of apoptosis by CWAuNPs in A498 cell was measured using apoptotic staining DAPI, Rhodamine 123, and H2DCFDA. The apoptotic activity of CWAuNPs was further confirmed with flow cytometric analysis. The molecular mechanism of CWAuNPs was analyzed with qPCR and immunoblotting analysis of caspases, proapoptotic, and antiapoptotic proteins.
Results:
The characterization of results of synthesized CWAuNPs satisfy the distinctive properties of a potent nanodrug. The results of apoptotic staining techniques confirm the induction of CWAuNPs in A498 by increasing the apoptotic Caspase 3,9, Bid, and Bad, and decreasing the antiapoptotic protein Bcl-2, Bcl-xl expressions, which is authentically proven by the qPCR and immunoblotting analysis.
Conclusion:
In conclusion, these results confirmed that biosynthesized CWAuNPs is a potent anticancer agent which induces apoptosis in the A498
renal carcinoma
cell line.
...
PMID:Apoptotic effect of green synthesized gold nanoparticles from
Curcuma wenyujin
extract against human renal cell carcinoma A498 cells. 3123 69